Perspective Therapeutics, Inc. (CATX)
2.81
+0.04
(+1.44%)
USD |
NYAM |
Sep 11, 16:00
2.815
0.00 (0.00%)
After-Hours: 20:00
Perspective Therapeutics Price to Book Value : 0.9899 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.9899 |
| September 10, 2026 | 0.9758 |
| September 09, 2026 | 1.053 |
| September 08, 2026 | 1.099 |
| September 04, 2026 | 1.103 |
| September 03, 2026 | 1.099 |
| September 02, 2026 | 1.092 |
| September 01, 2026 | 1.092 |
| August 31, 2026 | 1.113 |
| August 28, 2026 | 1.096 |
| August 27, 2026 | 1.120 |
| August 26, 2026 | 1.113 |
| August 25, 2026 | 1.159 |
| August 24, 2026 | 1.124 |
| August 21, 2026 | 1.162 |
| August 20, 2026 | 1.131 |
| August 19, 2026 | 1.226 |
| August 18, 2026 | 1.131 |
| August 17, 2026 | 1.134 |
| August 14, 2026 | 1.127 |
| August 13, 2026 | 1.092 |
| August 12, 2026 | 1.148 |
| August 11, 2026 | 1.120 |
| August 10, 2026 | 1.057 |
| August 07, 2026 | 1.057 |
| Date | Value |
|---|---|
| August 06, 2026 | 1.046 |
| August 05, 2026 | 1.036 |
| August 04, 2026 | 1.057 |
| August 03, 2026 | 1.060 |
| July 31, 2026 | 1.025 |
| July 30, 2026 | 1.053 |
| July 29, 2026 | 1.011 |
| July 28, 2026 | 1.011 |
| July 27, 2026 | 0.9934 |
| July 24, 2026 | 1.025 |
| July 23, 2026 | 1.039 |
| July 22, 2026 | 1.046 |
| July 21, 2026 | 1.050 |
| July 20, 2026 | 1.029 |
| July 17, 2026 | 1.053 |
| July 16, 2026 | 1.039 |
| July 15, 2026 | 1.134 |
| July 14, 2026 | 1.074 |
| July 13, 2026 | 1.088 |
| July 10, 2026 | 1.060 |
| July 09, 2026 | 1.117 |
| July 08, 2026 | 1.194 |
| July 07, 2026 | 1.205 |
| July 06, 2026 | 1.272 |
| July 02, 2026 | 1.279 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.034 |
| MiMedx Group, Inc. | 3.083 |
| ABVC BioPharma, Inc. | 2.455 |
| Enovis Corp. | 0.7527 |
| Edwards Lifesciences Corp. | 4.582 |
Price to Book Value Related Metrics
| PS Ratio | 640.48 |
| PEG Ratio | -5.088 |
| Price | 2.81 |
| Earnings Yield | -47.28% |
| Market Cap | 320.58M |
| PEGY Ratio | -5.088 |